|
|
|
Insider
Information: |
Ivers-Read Gillian C |
Relationship: |
See Remarks |
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
293,612 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,404 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
293,612 |
|
|
Total
Value |
$4,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
27
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
24
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,222.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
EVP, Development Opera... |
2008-03-07 |
0 |
2004-12-09 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
293,612 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
190,083 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
D |
$63.80 |
$224,066 |
D/D |
(3,512) |
186,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-01-16 |
4 |
AS |
$59.16 |
$177,480 |
D/D |
(3,000) |
183,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-02-15 |
4 |
AS |
$54.09 |
$162,270 |
D/D |
(3,000) |
180,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-06 |
4 |
D |
$58.43 |
$65,558 |
D/D |
(1,122) |
181,949 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
183,071 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
183,824 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-03-20 |
4 |
D |
$56.75 |
$47,046 |
D/D |
(829) |
182,995 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
183,620 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-06 |
4 |
D |
$47.70 |
$13,261 |
D/D |
(278) |
183,342 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
185,217 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-06-20 |
4 |
D |
$45.75 |
$37,927 |
D/D |
(829) |
184,388 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-05 |
4 |
D |
$35.75 |
$10,082 |
D/D |
(282) |
184,731 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
185,013 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
186,606 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-09-20 |
4 |
D |
$32.21 |
$26,702 |
D/D |
(829) |
185,777 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-12-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
625 |
186,402 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-12-04 |
4 |
S |
$21.23 |
$5,308 |
D/D |
(250) |
186,152 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-12-20 |
4 |
S |
$17.72 |
$14,690 |
D/D |
(829) |
187,198 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
188,027 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
190,257 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-05 |
4 |
S |
$29.29 |
$47,186 |
D/D |
(1,611) |
188,962 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
190,837 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-20 |
4 |
S |
$26.13 |
$21,688 |
D/D |
(830) |
190,007 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,312 |
191,044 |
0 |
- |
|
117 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|